Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01506973 |
|---|---|
| Brief Title: | A Phase I/II/Pharmacodynamic Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane to Inhibit Autophagy in Pancreatic Cancer |
| First Submitted : | January 3, 2012 |
| First Submitted that Met QC Criteria : | January 9, 2012 |
| First Posted : | January 10, 2012 (Estimate) |
| Last Update Submitted that Met QC Criteria : | March 29, 2022 |
| Last Update Posted : | March 31, 2022 |